MedTrace Logo

The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma

NCT00720668 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2009-02-09

No results posted yet for this study

Summary

This study aim to find out the risk of exacerbation of chronic hepatitis B after percutaneous radiofrequency ablation (RFA) or hepatectomy for HCC, and it's effect to treatment outcome.

Conditions

Interventions

PROCEDURE

radiofrequency ablation

radiofrequency ablation for HCC

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • min-shan chen, MD · Department of Hepatobilliary Surgery, Cancer Center, Sun Yat-sen University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2009-03-31
Completion
2010-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00720668 on ClinicalTrials.gov